EUVIMEDEUVIMED entdecken
Crossref

Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network

M Faron, A Naman, J Delahousse, S Hescot, J Hadoux, F Castinetti, D Drui, P Renoult-Pierre, R Libe, L Lamartina, S Leboulleux, A Al-Ghuzlan und 4 weitere

Journal of Endocrinological Investigation · 2024

DOI: 10.1007/s40618-024-02439-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von M Faron und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. matthieu.faron@gustaveroussy.fr. Hauptthemen laut MEDLINE: Mitotane, Adrenocortical Carcinoma, Adrenal Cortex Neoplasms, Antineoplastic Agents, Hormonal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitotaneAdrenocortical CarcinomaAdrenal Cortex NeoplasmsAntineoplastic Agents, HormonalLipoproteinsHumansMaleFemaleMiddle AgedProspective StudiesPrognosisAdultAgedFollow-Up StudiesSurvival Rate

Stichwörter der Autor:innen

Adrenocortical carcinomaLipoproteinMitotanePharmacokinetics

Substanzen

MitotaneAntineoplastic Agents, HormonalLipoproteins

Autor:innen und Institutionen

  • Department of Surgical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. matthieu.faron@gustaveroussy.fr.
  • INSERM 1018 CESP ONCOSTAT Team, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. matthieu.faron@gustaveroussy.fr.
  • Nuclear Medicine and Endocrine Unit, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France.
  • Pharmacology Department, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
  • Nuclear Medicine Unit, Institut Curie, 35 Rue Dailly, 92210, Saint Cloud, France.
  • Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de La Conception, 147 Boulevard Baille, 13005, Marseille, France.

Zitieren

APA

Faron, M., Naman, A., Delahousse, J., Hescot, S., Hadoux, J., Castinetti, F., Drui, D., Renoult-Pierre, P., Libe, R., Lamartina, L., Leboulleux, S., Al-Ghuzlan, A., Lombès, M., Paci, A., Baudin, E., & For Endocan-Comete Network (2024). Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02439-7

Vancouver

Faron M, Naman A, Delahousse J, Hescot S, Hadoux J, Castinetti F, et al. Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02439-7

BibTeX
@article{Faron2024,
  author = {Faron, M and Naman, A and Delahousse, J and Hescot, S and Hadoux, J and Castinetti, F and Drui, D and Renoult-Pierre, P and Libe, R and Lamartina, L and Leboulleux, S and Al-Ghuzlan, A and Lombès, M and Paci, A and Baudin, E and For Endocan-Comete Network, For Endocan-Comete Network},
  title = {Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  doi = {10.1007/s40618-024-02439-7}
}
Kostenlos starten →